Pub Date : 2023-09-01DOI: 10.1177/17557380231185470k
British Medical Association. Pressures in general practice data analysis. Available at: www.bma.org.uk/advice-and-support/nhsdelivery-and-workforce/pressures/pressures-in-general-prac tice-data-analysis (accessed 20 February 2023). General Medical Council (2023) Working under pressure: Working safely. Available at: www.gmc-uk.org/ethical-guidance/ethical-hub/ working-under-pressure-questions-and-answers (accessed on 20 February 2023). Leydon GM, , Stuart B, and Summers RH, et al. (2018) Findings from a feasibility study to improve GP elicitation of patient concerns in UK general practice consultations. Patient Education and Counseling 101(8): 1394–1402. DOI: 10.1016/j.pec.2018.03.009.
{"title":"AKT answer relating to hypercalcaemia","authors":"","doi":"10.1177/17557380231185470k","DOIUrl":"https://doi.org/10.1177/17557380231185470k","url":null,"abstract":"British Medical Association. Pressures in general practice data analysis. Available at: www.bma.org.uk/advice-and-support/nhsdelivery-and-workforce/pressures/pressures-in-general-prac tice-data-analysis (accessed 20 February 2023). General Medical Council (2023) Working under pressure: Working safely. Available at: www.gmc-uk.org/ethical-guidance/ethical-hub/ working-under-pressure-questions-and-answers (accessed on 20 February 2023). Leydon GM, , Stuart B, and Summers RH, et al. (2018) Findings from a feasibility study to improve GP elicitation of patient concerns in UK general practice consultations. Patient Education and Counseling 101(8): 1394–1402. DOI: 10.1016/j.pec.2018.03.009.","PeriodicalId":92790,"journal":{"name":"InnovAiT","volume":"147 1","pages":"470 - 470"},"PeriodicalIF":0.0,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"76747501","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-09-01DOI: 10.1177/17557380231185470b
A. Kotecha
Bilezikian J, Khan A, Silverberg S, et al. (2022) Evaluation and management of primary hyperparathyroidism: Summary statement and guidelines from the Fifth International Workshop. Journal of Bone and Mineral Research 37(11): 2293–2314. DOI: 10.1002/jbmr.4677. Clines GA (2011) Mechanisms and treatment of hypercalcemia of malignancy. Current Opinion in Endocrinology, Diabetes & Obesity 18(6): 339–346. DOI: 10.1097/MED.0b013e32834b4401. Dickens LT, Derman B and Alexander JT (2023) Endocrine Society Hypercalcemia of Malignancy Guidelines. JAMA Oncology 9(3): 430–431. DOI:10.1001/jamaoncol.2022.7941. Ishii H, Mihai R, Watkinson JC, et al. (2018) Systematic review of cure and recurrence rates following minimally invasive parathyroidectomy. BJS Open 2(6): 364–370. DOI: 10.1002/bjs5.77. Meng QH and Wagar EA (2015) Laboratory approaches for the diagnosis and assessment of hypercalcemia. Critical Reviews in Clinical Laboratory Sciences 52(3): 107–119. DOI: 10.3109/ 10408363.2014.970266. Minisola S, Pepe J, Piemonte S, et al. (2015) The diagnosis and management of hypercalcaemia. BMJ 350(jun02 15): h2723–h2723. DOI: 10.1136/bmj.h2723. NICE (2014) Bipolar disorder: Assessment and management. Available at: www.nice.org.uk/guidance/cg185 (accessed 13 February 2023). NICE (2019) Hyperparathyroidism (primary): Diagnosis, assessment, and initial management. Available at: www.nice.org.uk/ guidance/ng132 (accessed 13 February 2023). NICE (2023) BNF cinacalcet. Available at: https://bnf.nice.org.uk/ drugs/cinacalcet/#interactions (accessed 11 February 2023). Parathyroid UK (2023) Hyperparathyroidism. Available at: https:// parathyroiduk.org/hyperparathyroidism (accessed 13 February 2023). RCGP. Clinical topic guide: Metabolic problems and endocrinology. Available at: www.rcgp.org.uk/mrcgp-exams/gp-curriculum/clini cal-topic-guides#metabolic (accessed 14 February 2023). Silverberg SJ (2007) Vitamin D deficiency and primary hyperparathyroidism. Journal of Bone and Mineral Research 22(S2): V100–V104. DOI: 10.1359/jbmr.07s202. Varghese J, Rich T and Jimenez C (2011) Benign familial hypocalciuric hypercalcemia. Endocrine Practice 17: 13–17. DOI: 10.4158/EP10308.RA. Walker MD and Silverberg SJ (2018) Primary hyperparathyroidism. Nature Reviews Endocrinology 14(2): 115–125. DOI: 10.1038/ nrendo.2017.104. Yeh MW, Ituarte PHG, Zhou HC, et al. (2013) Incidence and prevalence of primary hyperparathyroidism in a racially mixed population. The Journal of Clinical Endocrinology and Metabolism 98(3): 1122–1129. DOI: 10.1210/jc.2012-4022.
{"title":"AKT question relating to further investigations","authors":"A. Kotecha","doi":"10.1177/17557380231185470b","DOIUrl":"https://doi.org/10.1177/17557380231185470b","url":null,"abstract":"Bilezikian J, Khan A, Silverberg S, et al. (2022) Evaluation and management of primary hyperparathyroidism: Summary statement and guidelines from the Fifth International Workshop. Journal of Bone and Mineral Research 37(11): 2293–2314. DOI: 10.1002/jbmr.4677. Clines GA (2011) Mechanisms and treatment of hypercalcemia of malignancy. Current Opinion in Endocrinology, Diabetes & Obesity 18(6): 339–346. DOI: 10.1097/MED.0b013e32834b4401. Dickens LT, Derman B and Alexander JT (2023) Endocrine Society Hypercalcemia of Malignancy Guidelines. JAMA Oncology 9(3): 430–431. DOI:10.1001/jamaoncol.2022.7941. Ishii H, Mihai R, Watkinson JC, et al. (2018) Systematic review of cure and recurrence rates following minimally invasive parathyroidectomy. BJS Open 2(6): 364–370. DOI: 10.1002/bjs5.77. Meng QH and Wagar EA (2015) Laboratory approaches for the diagnosis and assessment of hypercalcemia. Critical Reviews in Clinical Laboratory Sciences 52(3): 107–119. DOI: 10.3109/ 10408363.2014.970266. Minisola S, Pepe J, Piemonte S, et al. (2015) The diagnosis and management of hypercalcaemia. BMJ 350(jun02 15): h2723–h2723. DOI: 10.1136/bmj.h2723. NICE (2014) Bipolar disorder: Assessment and management. Available at: www.nice.org.uk/guidance/cg185 (accessed 13 February 2023). NICE (2019) Hyperparathyroidism (primary): Diagnosis, assessment, and initial management. Available at: www.nice.org.uk/ guidance/ng132 (accessed 13 February 2023). NICE (2023) BNF cinacalcet. Available at: https://bnf.nice.org.uk/ drugs/cinacalcet/#interactions (accessed 11 February 2023). Parathyroid UK (2023) Hyperparathyroidism. Available at: https:// parathyroiduk.org/hyperparathyroidism (accessed 13 February 2023). RCGP. Clinical topic guide: Metabolic problems and endocrinology. Available at: www.rcgp.org.uk/mrcgp-exams/gp-curriculum/clini cal-topic-guides#metabolic (accessed 14 February 2023). Silverberg SJ (2007) Vitamin D deficiency and primary hyperparathyroidism. Journal of Bone and Mineral Research 22(S2): V100–V104. DOI: 10.1359/jbmr.07s202. Varghese J, Rich T and Jimenez C (2011) Benign familial hypocalciuric hypercalcemia. Endocrine Practice 17: 13–17. DOI: 10.4158/EP10308.RA. Walker MD and Silverberg SJ (2018) Primary hyperparathyroidism. Nature Reviews Endocrinology 14(2): 115–125. DOI: 10.1038/ nrendo.2017.104. Yeh MW, Ituarte PHG, Zhou HC, et al. (2013) Incidence and prevalence of primary hyperparathyroidism in a racially mixed population. The Journal of Clinical Endocrinology and Metabolism 98(3): 1122–1129. DOI: 10.1210/jc.2012-4022.","PeriodicalId":92790,"journal":{"name":"InnovAiT","volume":"21 1","pages":"441 - 441"},"PeriodicalIF":0.0,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"88568757","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
扫码关注我们
求助内容：
应助结果提醒方式：